Patent Assignment
Reel/Frame 073800/0407
Assignment of Assignor's Interest
Recorded: 2025-11-24
Pages: 3
Assignor
SHANNON, PATRICK
Executed: 2017-01-24
Assignee
CANCER PREVENTION PHARMACEUTICALS, INC.
1760 E. RIVER ROAD, SUITE 250, TUCSON, ARIZONA, 85718
Covered Property
(1)
Eflornithine and Sulindac, Fixed Dose Combination Formulation
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 30, 2025
From: PANBELA THERAPEUTICS, INC.; PANBELA RESEARCH, INC.; CANCER PREVENTION PHARMACEUTICALS, INC.
To: CREATIVE PLANNING BUSINESS ALLIANCE LLC
Reel/Frame 072735/0859 →
Assignment of Assignor's Interest
Nov 3, 2025
From: CREATIVE PLANNING BUSINESS ALLIANCE, LLC
To: USWM, LLC
Reel/Frame 072766/0028 →
Assignment of Assignor's Interest
Nov 24, 2025
From: DUCASSOU, JEAN
To: SANOFI WINTHROP INDUSTRIE
Reel/Frame 073020/0323 →
Assignment of Assignor's Interest
Nov 24, 2025
From: BRAVO GONZALEZ, ROBERTO CARLOS
To: TILLOTTS PHARMA AG
Reel/Frame 073799/0032 →
Assignment of Assignor's Interest
Nov 24, 2025
From: SANOFI WINTHROP INDUSTRIE S.A.
To: CANCER PREVENTION PHARMACEUTICALS, INC.
Reel/Frame 073799/0085 →
Assignment of Assignor's Interest
Nov 24, 2025
From: TILLOTTS PHARMA AG
To: CANCER PREVENTION PHARMACEUTICALS, INC.
Reel/Frame 073800/0690 →